In the disproportionate analysis of SOCs, the significant signals for ticagrelor were cardiac disorders (ROR 4.87, PRR 4.46), respiratory disorders (ROR 2.45, PRR 2.28), and vascular disorders (ROR 2.22, PRR 2.16). The gene discussed is CISH; the disease is vascular disorder.